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Abstract
Introduction—This study estimated the per-victim U.S. lifetime cost of rape.
Methods—Data from previous studies was combined with current administrative data and 2011 
U.S. National Intimate Partner and Sexual Violence Survey data in a mathematical model. Rape 
was defined as any lifetime completed or attempted forced penetration or alcohol- or drug-
facilitated penetration, measured among adults not currently institutionalized. Costs included 
attributable impaired health, lost productivity, and criminal justice costs from the societal 
perspective. Average age at first rape was assumed to be 18 years. Future costs were discounted by 
3%. The main outcome measures were the average per-victim (female and male) and total 
population discounted lifetime cost of rape. Secondary outcome measures were marginal outcome 
probabilities among victims (e.g., suicide attempt) and perpetrators (e.g., incarceration) and 
associated costs. Analysis was conducted in 2016.
Results—The estimated lifetime cost of rape was $122,461 per victim, or a population economic 
burden of nearly $3.1 trillion (2014 U.S. dollars) over victims’ lifetimes, based on data indicating 
>25 million U.S. adults have been raped. This estimate included $1.2 trillion (39% of total) in 
medical costs; $1.6 trillion (52%) in lost work productivity among victims and perpetrators; $234 
billion (8%) in criminal justice activities; and $36 billion (1%) in other costs, including victim 
property loss or damage. Government sources pay an estimated $1 trillion (32%) of the lifetime 
economic burden.
Conclusions—Preventing sexual violence could avoid substantial costs for victims, perpetrators, 
healthcare payers, employers, and government payers. These findings can inform evaluations of 
interventions to reduce sexual violence.
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An estimated 19.3% of U.S. women and 1.7% of men have been raped during their lifetime.1 
Sexual violence victimization is associated with poor short- and long-term physical and 
mental health outcomes.2,3
Few studies have quantified the per-victim lifetime economic cost of sexual violence, which 
at a minimum includes victims’ impaired health, as well as lost productivity and criminal 
justice activities. A per-victim cost here refers to the value of a person entirely avoiding a 
particular exposure. Previous studies have estimated related cost dimensions—such as cost 
per sexual assault incident4–8—but largely have not accounted for victims’ long-term health. 
The aim of this study was to use data from previous studies with current administrative and 
sexual violence surveillance data to estimate the per-victim U.S. lifetime cost and total 
population economic burden of rape among adults not currently institutionalized.
METHODS
Study information reported according to Consolidated Health Economic Evaluation 
Reporting Standards.9 Model inputs included the number of U.S. adult (aged ≥18 years) 
women and men with any lifetime (including childhood) and past 12–month incidence of 
rape; selected attributable—or marginal—health and other outcomes associated with rape 
from administrative data and previous studies (hereafter, reference studies); and the marginal 
cost of those outcomes. Marginal outcome refers to the proportion of victims with an 
outcome beyond the proportion among non-victims, and is used to calculate the attributable 
cost of rape. Medical, lost work productivity, and criminal justice costs were included. The 
main outcome measures were:
1. lifetime cost of rape per victim; and
2. lifetime cost of rape in the U.S. population (or economic burden) of currently 
non-institutionalized adults (hereafter, U.S. population), calculated as the 
lifetime cost per victim multiplied by the population number of victims.
This analysis used a lifetime time horizon from the societal perspective. Previous studies of 
lifetime per-person health costs have identified a meaningful age of inception—for example, 
age 6 years for nonfatal child maltreatment10 (estimated cost: $210,012 as 2010 U.S. dollars 
[USD], or $225,408 as 2014 USD11) and age 24 years for smoking12 (estimated cost: 
$220,000 for men and $106,000 for women as 2000 USD, or $292,010 and $139,119 as 
2014 USD11). The authors did not find a robust estimated average age of first rape among 
victims, although it is known that the age of first completed rape was <18 years for 42% of 
female victims (and <25 years for 80% of female victims) and <10 years for 25% of male 
victims.13 The present model assessed lifetime unit costs assuming an average age of first 
rape victimization of 18 years. Costs incurred after the first year were discounted by 3%14 
and presented as 2014 USD, inflated using selected indices.11,15 The analysis was conducted 
in 2016 and used publicly available data.
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Definition and Prevalence of Rape
The economic burden estimate is based on the estimated number of currently non-
institutionalized men and women who reported having been raped at some point during their 
lives in the 2011 U.S. National Intimate Partner and Sexual Violence Survey (NISVS)1 (data 
collection, January–December 2011) where rape was defined as completed or attempted 
penetration of the victim through the use or threats of physical force or when the victim was 
drunk, high, drugged, or passed out and unable to consent (Table 1).
Outcomes and Unit Costs
Rape outcomes, identified through a targeted literature search, were included based on 
reference studies’ representativeness (Appendix Table 1, available online). National studies 
and meta-analyses addressing both male and female victims were prioritized. Outcomes had 
to be reported in a way that facilitated calculation of victims’ marginal probability of the 
outcome; for example, the outcome prevalence among non-victims and an AOR of the 
relationship between the outcome and respondents’ experience of rape.44 Studies that 
assessed outcomes among adult (i.e., aged ≥18 years) respondents and aligned with the 
NISVS rape definition were prioritized. Unit costs represented the attributable cost of 
analyzed outcomes, based on direct comparison of affected and unaffected individuals 
(Appendix Table 2, available online). Comprehensive lifetime unit costs that included both 
medical care and lost work productivity were prioritized. Where only annual unit costs were 
available, lifetime costs were estimated by multiplying the annual cost over the age range of 
respondents in the cost reference study (Appendix Table 3, available online), bounded by the 
average assumed age at first rape victimization (i.e., 18 years) and current life expectancy 
(i.e., 79 years).45 The cost of prevention efforts was excluded.
Average annual data from the 2010–2014 U.S. National Crime Victimization Survey 
indicated 10.9% (n = 18,012/165,034 survey weighted) of attempted or completed rape 
victimizations (including male and female victims) involved victim property loss or damage, 
valued at an average $219 per affected victim (Table 1) (U.S. Department of Justice, Bureau 
of Justice Statistics, personal communication, 2015).
Among attempted or completed rape victimizations (N=216,570 surveyed weighted) from 
annual average 1995–2014 National Crime Victimization Survey data, 5.3% of victims were 
treated for nonfatal injuries in a doctor’s office, 12.1% in an emergency department, and 
1.0% as inpatients (Table 1) (U.S. Department of Justice, Bureau of Justice Statistics, 
personal communication, 2015). Unit costs were estimated payment for a doctor’s visit16 
and the discounted lifetime medical cost associated with an emergency department visit or 
hospital admission for sexual assault (Pacific Institute for Research and Evaluation, personal 
communication, 2016) (Table 1). In 2011, there were an estimated 18 murders associated 
with rape crimes (Appendix Table 1, available online).17 Unit costs were based on an 
estimated lifetime cost of medical care and lost productivity due to homicide.18
Data from a national sample of women (N=3,031 respondents) indicated that 4.8% of 
completed penetration rape victims experienced rape-related pregnancy (Table 1).19 Among 
a small sample of rape-related pregnancies (N=34), 11.3% resulted in spontaneous abortion, 
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50.0% in medically assisted abortion, 32.3% of women kept the baby, and 5.9% of women 
gave the baby up for adoption.19 Unit costs were estimated payments for medical treatment 
for spontaneous abortion,23 medically assisted abortion,22 pregnancy and delivery,20 and the 
public payer cost of adoption from age 0 to 18 years (i.e., social services)21 applied to the 
estimated proportion of women with rape-related pregnancy by outcome among those with 
lifetime experience of completed penetration rape among all women victims of attempted 
and completed rape in 2011 NISVS (n=13,826,000/23,305,000, or 59%) (Table 1).1
Female victims of intimate partner rape aged ≥18 years (N=322,230 victimizations, survey 
weighted) documented in the National Violence Against Women Survey was calculated as 
an average 3.6 productive days missed per victim (Appendix Table 2 [available online] 
provides calculations).46 This number of days was multiplied by an estimated U.S. 
population (aged ≥15 years) daily production value24 to estimate the value of short-term lost 
productivity due to rape ($516 in 2014 USD) (Table 1).
Funding for victims’ services through the criminal justice system at the federal, state, and 
local levels—including U.S. Department of Justice grants and Violence Against Women Act 
(Title IV, P.L. 103-322)47 funding—are comprehensively included in the criminal justice 
estimates through a top-down accounting approach (Appendix reports calculation details, 
available online). This approach was deemed the best use of available data, but means the 
authors could not identify the cost of individual victim services (e.g., rape kit processing). 
Although previous studies have estimated the cost of annual victim services for two state 
governments,5,8 it was determined infeasible to comprehensively and accurately assess the 
proportion of victims accessing services and the cost of response (as opposed to prevention) 
services per victim using a bottom-up accounting approach.
A meta-analysis of studies published in 1980–2008 indicated significantly higher observed 
prevalence of mental health outcomes—anxiety, depression, eating disorder, post-traumatic 
stress disorder, and suicide attempt—among adolescent and adult respondents with lifetime 
(primarily childhood) experience of sexual abuse (Table 1).2 The proportion of nonfatal 
suicide attempts requiring medical care was estimated using data for men (59.0% of 
attempts) and women (31.1% of attempts) in a separate national sample study of adolescent 
rape victims.29 Unit costs were estimated lost work productivity and medical costs for 
anxiety disorder,25 major depressive disorder,26 eating disorders,27 post-traumatic stress 
disorder,25,28 and medically serious nonfatal suicide attempts18,30 (Table 1).
The 2005 Behavioral Risk Factor Surveillance System survey indicated significantly higher 
observed prevalence of excess alcohol and tobacco use among adults (aged ≥18 years, 
N=115,030 respondents) with lifetime experience of unwanted attempted or completed sex 
(Table 1).3 Unit costs were attributable estimated lost work productivity and medical costs 
for excess alcohol use31,32 and smoking12 (Table 1). The 1990–1992 National Comorbidity 
Survey documented significantly higher prevalence of drug problems among adults (aged 
≥15 years, N=5,877 respondents) who were raped or molested during childhood or 
adolescence (Table 1),33 supporting other research among a national sample of women.48,49 
Unit costs were estimated lost productivity and medical costs34,35 (Table 1).
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The 2005 Behavioral Risk Factor Surveillance System data indicated significantly higher 
observed prevalence of asthma and joint conditions among sexual violence victims (Table 
1).3 Unit costs were estimated lost work productivity and medical payments for asthma36 
and joint pain39 (Table 1). Kentucky Women’s Health Registry data indicated significantly 
higher observed prevalence of cervical cancer among women (aged ≥15 years, N=4,732 
respondents) with lifetime forced sexual experiences (Table 1).37 Unit costs were estimated 
medical payments38 and lost productivity38 attributable to cancer, assigned among the 
estimated number of women with lifetime completed penetration rape in 2011 U.S. NISVS 
(n=13,826,000) (Table 1). A U.S. health plan study indicated a higher observed prevalence 
of sexually transmitted infections among adults (aged ≥19 years, N=9,323 respondents) who 
experienced attempted or completed rape during childhood or adolescence (age ≤ 18 
years)40 (Table 1). Unit cost were estimated medical costs41,42 and lost work productivity43 
(Table 1).
An attribution method was used to estimate the per-victim discounted lifetime average 
criminal justice cost associated with sexual violence among total annual U.S. government 
criminal justice spending (Table 2 and Appendix [available online]).50 Lost productivity due 
to incarceration is the annual production value of the U.S. non-institutional population 
multiplied by the average estimated number of years sexual violence perpetrators are 
incarcerated (Tables 1 and 2, Appendix [available online]).
Analysis
The marginal probability of selected outcomes was multiplied by associated unit costs to 
estimate the per-person lifetime cost of rape, separately for men and women. The sex-
specific, per-person estimated cost of rape was multiplied by the estimated number of men 
and women with lifetime experience of rape to estimate the total U.S. lifetime burden of 
rape. Government costs were assessed as the sum of criminal justice and adoption costs, plus 
the estimated government share of all medical spending (i.e., 59.8%).63
RESULTS
The present-value, per-victim estimated lifetime cost of rape was $122,461, or $3.1 trillion 
for all victims, based given new information about victim outcomes or unit on 23 million 
U.S. women and 2 million men with costs. Barring substantial changes to the per-victim cost 
lifetime experience of rape (Table 1).
DISCUSSION
The per-victim lifetime cost of rape ($122,461) can be interpreted as the cost averted for 
each potential victim who avoids rape. The per-victim estimate could change given new 
information about victim outcomes or unit costs. Barring substantial changes to the per-
victim cost estimate, the lifetime economic burden of rape estimate ($3.1 trillion) will 
remain relatively stable; this estimate reflects the per-victim cost multiplied by the number 
of U.S. adults with lifetime experience of rape, and such a large population experiences 
modest incremental demographic changes. The estimated number of victims with rape 
experience in the past 12 months had a minor impact on the economic burden through the 
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criminal justice and fatalities estimates. The economic burden represents costs over victims’ 
lifetimes. Though the authors do not know what proportion of victims in the previous 12 
months (an estimated 1,929,000 women1 and 219,000 men [unpublished data]) were first-
time victimizations, applying this study’s per-victim cost estimate to that annual number of 
victims yields an approximate annual economic burden of $263 billion.
The per-victim estimate is the minimal identifiable cost of rape. This study did not include 
non-monetary elements, sometimes presented as intangible costs—a monetized version of 
victims’ pain and suffering.4,8 Previous studies have estimated the per-offense cost of rape 
and sexual assault to be $87,000 (1993 USD) to $240,776 (2008 USD) (or approximately 
$130,775 to $263,772 as 2014 USD11), of which 80% to 95% were intangible costs.4–6,8 
Recognizing victims’ pain and suffering is unquestionably important, but must be weighed 
against the conceptual and computational challenges of monetizing pain and suffering.64 
Costs to victims’ and perpetrators’ friends and families, and costs of other forms of sexual 
violence (e.g., being made to penetrate or sexual coercion) were not included. NISVS 
estimates do not include the currently institutionalized population, though would capture 
experiences among the previously institutionalized. Health outcomes that could be linked to 
specific attributable costs were included, though activity limitations, gastrointestinal 
symptoms, high cholesterol, HIV risk factors, non-specific pain, overweight, and urinary 
problems have higher prevalence among sexual violence victims.3,65,66 Many lost 
productivity unit estimates included only employed respondents, and valued respondents’ 
productivity using the human capital approach (i.e., lost wages). This approach, though 
commonly used, undervalues lost productivity overall and undervalues female losses, in 
particular, because women are often paid less than men. Many lost productivity estimates 
did not include mortality. Long-term lost productivity among rape victims not diagnosed 
with any of the analyzed outcomes was not included.
Discounting assumed victims’ age at first rape was 18 years, which underestimates/
overestimates costs among victims with first rape at age <18 years/> 18 years. If one instead 
applies the average age of rape victimizations among adolescents and adults—27 years67—
the estimated cost per victim decreases modestly to $119,277, with a population economic 
burden still exceeding $3 trillion. Too few reference study estimates included measures of 
dispersion for a meaningful probabilistic sensitivity analysis (Appendix Tables 1 and 2, 
available online). Based on available data, the authors have not included the medical cost of 
follow-up visits for sexually transmitted infection testing that takes place after an initial 
medical visit for rape treatment. Identifiable double counting of costs includes the following: 
HIV costs appear in both sexually transmitted infection and illicit drug use unit costs, and 
some costs for anxiety and drug and alcohol dependence are included in the depression unit 
cost (Appendix Tables 1 and 2, available online). Substance use constitutes approximately a 
quarter of the per-victim cost; crime costs are a major component of contributing unit costs 
for substance abuse, and a small portion (<1%) of those unit costs included research and 
prevention activities related to alcohol and drugs.12,31,32,34,35 Some reference studies 
focused on outcomes exclusively among adults who experienced childhood rape (Appendix 
Table 1, available online). The cost of some lifetime experiences was inferred from available 
annual cost data (Appendix Table 3, available online), which implicitly assumes an accurate 
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distribution of patients at all stages of a particular outcome (i.e., acute, recurring, remission) 
in reference studies’ annual estimates.
Limitations
This study is notably limited by inexact timelines related to rape occurrence during victims’ 
lifetimes, number of rape incidents per victim, number of victims per perpetrator, onset of 
attributable health outcomes, and treatment of those outcomes. This study’s estimates are per 
victim, rather than per victimization, which certainly underestimates consequences among 
some victims and the acute costs associated with victimization.68 Another major limitation 
is that this study assumed that rape is the cause of victims’ higher observed prevalence of 
health-related conditions, although the status of these conditions as risk factors for, 
correlates with, or outcomes of sexual violence is complex.69 Future analysis of longitudinal 
data identifying sexual violence and health outcomes might address these issues, along with 
issues related to timing of rape exposure and the effects of multiple victimizations.
CONCLUSIONS
Despite limitations, this study’s economic burden estimate included more comprehensive 
information on victims’ lifetime mental and physical health than previous estimates. This 
study incorporated new national surveillance data from NISVS indicating rape affects many 
times more individuals than other sources have suggested previously. These findings can 
inform evaluations of interventions to prevent sexual violence, identifying cost-effective 
approaches to eliminate rape and its substantial impact on public health.
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Acknowledgments
Authors acknowledge Michelle Berlin, Kathryn McCollister, and Manon Ruben for their contributions to a 
literature review of the health consequences and costs of sexual violence victimization conducted to support this 
study through Centers for Disease Control and Prevention contract 200-2012-F-53476 to Quality Resource Systems 
Inc. Authors acknowledge Jenna Truman and Lynn Langton at the U.S. Department of Justice, Bureau of Justice 
Statistics, for assistance with data from the National Crime Victimization Survey. Authors acknowledge Bruce A. 
Lawrence at the Pacific Institute for Research and Evaluation for unpublished cost estimates of medical treatment 
(emergency department and hospitalization) for rape.
The findings and conclusions in this report are those of the authors and do not necessarily represent the official 
position of the Centers for Disease Control and Prevention.
References
1. Breiding MJ, Smith SG, Basile KC, Walters ML, Chen J, Merrick MT. Prevalence and 
characteristics of sexual violence, stalking, and intimate partner violence victimization— National 
Intimate Partner and Sexual Violence Survey, United States 2011. MMWR Surveill Summ. 2014; 
63(8):1–18.
2. Chen LP, Murad MH, Paras ML, et al. Sexual abuse and lifetime diagnosis of psychiatric disorders: 
systematic review and meta-analysis. Mayo Clin Proc. 2010; 85(7):618–629. http://dx.doi.org/
10.4065/mcp.2009.0583. [PubMed: 20458101] 
Peterson et al. Page 7













3. Smith SG, Breiding MJ. Chronic disease and health behaviours linked to experiences of non-
consensual sex among women and men. Public Health. 2011; 125(9):653–659. http://dx.doi.org/
10.1016/j.puhe.2011. [PubMed: 21855097] 
4. McCollister KE, French MT, Fang H. The cost of crime to society: new crime-specific estimates for 
policy and program evaluation. Drug Alcohol Depend. 2010; 108(1-2):98–109. http://dx.doi.org/
10.1016/j.drugalcdep.2009.12.002. [PubMed: 20071107] 
5. Miller, T., Taylor, D., Sheppard, M. Costs of Sexual Violence in Minnesota. St Paul, MN: Minnesota 
Department of Health; 2007. 
6. Miller, TR., Cohen, MA., Wiersema, B. Victim Costs and Consequences: A New Look. Washington, 
DC: National Institute of Justice, Office of Justice Programs, U.S. Department of Justice; 1996. 
7. Miller TR, Cohen MA, Rossman SB. Victim costs of violent crime and resulting injuries. Health Aff 
(Millwood). 1993; 12(4):186–197. http://dx.doi.org/10.1377/hlthaff.12.4.186. 
8. Yang J, Miller TR, Zhang N, LeHew B, Peek-Asa C. Incidence and cost of sexual violence in Iowa. 
Am J Prev Med. 2014; 47(2):198–202. http://dx.doi.org/10.1016/j.amepre.2014.04.005. [PubMed: 
24930620] 
9. Husereau D, Drummond M, Petrou S, et al. Consolidated Health Economic Evaluation Reporting 
Standards (CHEERS)—explanation and elaboration: a report of the ISPOR Health Economic 
Evaluation Publication Guidelines Good Reporting Practices Task Force. Value Health. 2013; 16(2):
231–250. http://dx.doi.org/10.1016/j.jval.2013.02.002. [PubMed: 23538175] 
10. Fang X, Brown DS, Florence CS, Mercy JA. The economic burden of child maltreatment in the 
United States and implications for prevention. Child Abuse Negl. 2012; 36(2):156–165. http://
dx.doi.org/10.1016/chiabu.2011.10.006. [PubMed: 22300910] 
11. U.S. Bureau of Economic Analysis. [December 28, 2015] Table 1.1.4: Price indexes for gross 
domestic product. www.bea.gov/itable/. Published December 22, 2015
12. Sloan, F., Ostermann, J., Picone, G., Conover, C., Taylor, D. The Price of Smoking. Cambridge, 
MA: MIT Press; 2004. 
13. Black, MC., Basile, KC., Breiding, MJ., et al. The National Intimate Partner and Sexual Violence 
Survey (NISVS) 2010 Summary Report. Atlanta, GA: National Center for Injury Prevention and 
Control, CDC; 2011. 
14. Gold M. Panel on cost-effectiveness in health and medicine. Med Care. 1996; 
34(12(suppl)):DS197–D199. [PubMed: 8969326] 
15. U.S. Bureau of Economic Analysis. [December 28 2015] Table 2.5.4: Price indexes for personal 
consumption expenditures by function. www.bea.gov/itable/. Published August 6 2015
16. Machlin, SR., Adams, SA. Statistical Brief #484: Expenses for Office-Based Physician Visits by 
Specialty, 2013. Rockville, MD: Agency for Healthcare Research and Quality; 2015. 
17. U.S. Federal Bureau of Investigation. Table 12. Expanded homicide data—murder circumstances 
2009–2013. Washington, DC: U.S. Department of Justice; 2013. 
18. Centers for Disease Control and Prevention (CDC). Web-based Injury Statistics Query and 
Reporting System (WISQARS), cost of injury reports 2010, both sexes, all ages, United States. 
www.cdc.gov/injury/wisqars/index.html Published 2010
19. Holmes MM, Resnick HS, Kilpatrick DG, Best CL. Rape-related pregnancy: estimates and 
descriptive characteristics from a national sample of women. Am J Obstet Gynecol. 1996; 175(2):
320–324. http://dx.doi.org/10.1016/S0002-9378(96)70141-2. [PubMed: 8765248] 
20. Truven Health Analytics. The Cost of Having a Baby in the United States. Ann Arbor, MI: Truven 
Health Analytics; 2013. 
21. Barth R, Chung K, Wildfire J, Shenyang G. A comparison of the governmental costs of long-term 
foster care and adoption. Soc Serv Rev. 2006; 80(1):127–158. http://dx.doi.org/10.1086/499339. 
22. Jerman J, Jones RK. Secondary measures of access to abortion services in the United States 2011 
and 2012 gestational age limits, cost, and harassment. Womens Health Issues. 2014; 24(4):e419–
e424. http://dx.doi.org/10.1016/j.whi.2014.05.002. [PubMed: 24981401] 
23. Jerman J, Jones RK. Secondary measures of access to abortion services in the United States 2011 
and 2012: gestational age limits, cost, and harassment. Womens Health Issues. 2014; 24(4):e419–
e424. http://dx.doi.org/10.1016/j.whi.2014.05.002. [PubMed: 24981401] 
Peterson et al. Page 8













24. Grosse SD, Krueger KV, Mvundura M. Economic productivity by age and sex: 2007 estimates for 
the United States. Med Care. 2009; 47(7(suppl 1)):S94–S103. http://dx.doi.org/10.1097/MLR.
0b013e31819c9571. [PubMed: 19536021] 
25. Greenberg PE, Sisitsky T, Kessler RC, et al. The economic burden of anxiety disorders in the 
1990s. J Clin Psychiatry. 1999; 60(7):427–435. http://dx.doi.org/10.4088/JCP.v60n0702. 
[PubMed: 10453795] 
26. Greenberg PE, Fournier AA, Sisitsky T, Pike CT, Kessler RC. The economic burden of adults with 
major depressive disorder in the United States (2005 and 2010). J Clin Psychiatry. 2015; 76(2):
155–162. http://dx.doi.org/10.4088/JCP.14m09298. [PubMed: 25742202] 
27. Samnaliev M, Noh HL, Sonneville KR, Austin SB. The economic burden of eating disorders and 
related mental health comorbidities: an exploratory analysis using the U.S. Medical Expenditures 
Panel Survey. Prev Med Rep. 2015; 2:32–34. http://dx.doi.org/10.1016/j.pmedr.2014. [PubMed: 
26844048] 
28. Ivanova JI, Birnbaum HG, Chen L, et al. Cost of post-traumatic stress disorder vs major depressive 
disorder among patients covered by medicaid or private insurance. Am J Manag Care. 2011; 
17(8):e314–e323. [PubMed: 21851139] 
29. Tomasula JL, Anderson LM, Littleton HL, Riley-Tillman TC. The association between sexual 
assault and suicidal activity in a national sample. Sch Psychol Q. 2012; 27(2):109–119. http://
dx.doi.org/10.1037/a0029162. [PubMed: 22774785] 
30. Corso PS, Mercy JA, Simon TR, Finkelstein EA, Miller TR. Medical costs and productivity losses 
due to interpersonal and self-directed violence in the United States. Am J Prev Med. 2007; 32(6):
474–482. http://dx.doi.org/10.1016/j.amepre.2007.02.010. [PubMed: 17533062] 
31. Sacks JJ, Gonzales KR, Bouchery EE, Tomedi LE, Brewer RD. 2010 national and state costs of 
excessive alcohol consumption. Am J Prev Med. 2015; 49(5):e73–e79. http://dx.doi.org/10.1016/
j.amepre.2015.05.031. [PubMed: 26477807] 
32. Bouchery EE, Harwood HJ, Sacks JJ, Simon CJ, Brewer RD. Economic costs of excessive alcohol 
consumption in the U.S., 2006. Am J Prev Med. 2011; 41(5):516–524. http://dx.doi.org/10.1016/
j.amepre.2011.06.045. [PubMed: 22011424] 
33. Molnar BE, Buka SL, Kessler RC. Child sexual abuse and subsequent psychopathology: results 
from the National Comorbidity Survey. Am J Public Health. 2001; 91(5):753–760. http://
dx.doi.org/10.2105/AJPH.91.5.753. [PubMed: 11344883] 
34. U.S. Department of Justice. The economic impact of illicit drug use on American Society. 
Washington, DC: National Drug Intelligence Center; 2011. 
35. U.S. DHHS. Results from the 2007 National Survey on Drug Use and Health: national findings 
(NSDUH Series H-34, DHHS Publication No SMA 08-4343. Rockville, MD: Substance Abuse 
and Mental Health Services Administration, Office of Applied Studies; 2009. 
36. Barnett SB, Nurmagambetov TA. Costs of asthma in the United States 2002-2007. J Allergy Clin 
Immunol. 2011; 127(1):145–152. http://dx.doi.org/10.1016/j.jaci.2010.10.020. [PubMed: 
21211649] 
37. Coker AL, Hopenhayn C, DeSimone CP, Bush HM, Crofford L. Violence against women raises 
risk of cervical cancer. J Womens Health (Larchmt). 2009; 18(8):1179–1185. http://dx.doi.org/
10.1089/jwh.2008.1048. [PubMed: 19630537] 
38. Ekwueme DU, Yabroff KR, Guy GP Jr. Medical costs and productivity losses of cancer survivors
—United States 2008-2011. MMWR Morb Mortal Wkly Rep. 2014; 63(23):505–510. [PubMed: 
24918485] 
39. Gaskin, D., Richard, R. Appendix C: The economic costs of pain in the United States. Washington, 
DC: IOM Committee on Advancing Pain Research, Care, and Education; 2011. Relieving Pain in 
America: a blueprint for transforming prevention, care, education, and research. 
40. Hillis SD, Anda RF, Felitti VJ, Nordenberg D, Marchbanks PA. Adverse childhood experiences 
and sexually transmitted diseases in men and women: a retrospective study. Pediatrics. 2000; 
106(1):E11. http://dx.doi.org/10.1542/peds.106.1.e11. [PubMed: 10878180] 
41. Owusu-Edusei K Jr, Chesson HW, Gift TL, et al. The estimated direct medical cost of selected 
sexually transmitted infections in the United States, 2008. Sex Transm Dis. 2013; 40(3):197–201. 
http://dx.doi.org/10.1097/OLQ.0b013e318285c6d2. [PubMed: 23403600] 
Peterson et al. Page 9













42. Chesson HW, Ekwueme DU, Saraiya M, Watson M, Lowy DR, Markowitz LE. Estimates of the 
annual direct medical costs of the prevention and treatment of disease associated with human 
papil-lomavirus in the United States. Vaccine. 2012; 30(42):6016–6019. http://dx.doi.org/10.1016/
j.vaccine.2012.07.056. [PubMed: 22867718] 
43. Owusu-Edusei K Jr, Roby TM, Chesson HW, Gift TL. Productivity costs of nonviral sexually 
transmissible infections among patients who miss work to seek medical care: evidence from claims 
data. Sex Health. 2013; 10(5):434–437. http://dx.doi.org/10.1071/SH13021. [PubMed: 23987746] 
44. Zhang J, Yu KF. What’;s the relative risk? A method of correcting the odds ratio in cohort studies 
of common outcomes. JAMA. 1998; 280(19):1690–1691. http://dx.doi.org/10.1001/jama.
280.19.1690. [PubMed: 9832001] 
45. Xu J, Murphy SL, Kochanek KD, Bastian BA. Deaths: final data for 2013. Natl Vital Stat Rep. 
2016; 64(2):1–119. [PubMed: 26905861] 
46. Centers for Disease Control and Prevention (CDC). Costs of Intimate Partner Violence Against 
Women in the United States. Atlanta, GA: CDC; 2003. 
47. Laney, G. Violence Against Women Act: History and Federal Funding (RL30871. Washington, 
DC: U.S. Congressional Research Service; 2010. 
48. Kilpatrick, DG., Resnick, HS., Ruggiero, KJ., Conoscenti, LM., McCauley, JM. Drug-facilitated, 
incapacitated, and forcible rape: a national study, NIJ 219181. Washington, DC: National Institute 
of Justice; 2007. 
49. Zinzow HM, Resnick HS, McCauley JL, Amstadter AB, Ruggiero KJ, Kilpatrick DG. Prevalence 
and risk of psychiatric disorders as a function of variant rape histories: results from a national 
survey of women. Soc Psychiatry Psychiatr Epidemiol. 2012; 47(6):893–902. Supplemental 
analysis received from authors November 2015. [PubMed: 21603967] 
50. U.S. Department of Justice. Justice Expenditure and Employment Extracts, NCJ 248628. 
Washington, DC: U.S. Department of Justice; 2015. Table 1. Percent distribution of expenditure 
for the justice system by type of government, fiscal 2012. 
51. U.S. Federal Bureau of Investigation. Crime in the United States 2013. Washington, DC: U.S. 
Department of Justice; 2013. Table 29. Estimated number of arrests, Rape—revised definition. 
52. U.S. Department of Justice. Correctional populations in the United States, 2013, NCJ 248479. 
Washington, DC: U.S. Department of Justice; 2014. Table 1. Estimated number of persons 
supervised by adult correctional systems, by correctional status, 2000, 2005, and 2010–2013. 
53. U.S. Department of Justice. Felony defendants in large urban counties, 2009—statistical tables, 
NCJ 243777. Washington, DC: U.S. Department of Justice; 2013. Table 21. Adjudication outcome 
for felony defendants in the 75 largest counties, by most serious arrest charge. 
54. U.S. Department of Justice. Probation and parole in the United States, 2013, NCJ 248029. 
Washington, DC: U.S. Department of Justice; 2014. Table 3. Rate of probation exits, by type of 
exit, 2008–2013. 
55. U.S. Department of Justice. Profile of jail inmates, NCJ 201932. Washington, DC: U.S. 
Department of Justice; 2004. Table 6. Length of sentence and time expected to be served of 
inmates sentenced to jail, by offense, 2002. 
56. U.S. Department of Justice. Bureau of Justice Statistics, state court sentencing of convicted felons, 
statistical tables, NCJ 217995. Washington, DC: U.S. Department of Justice; 2007. Table 1.3. 
Mean state prison sentence and estimated time to be served in prison, by offenses, 2004. 
57. U.S. Department of Justice. Survey of inmates in state correctional facilities. Bureau of Justice 
Statistics, National Prisoner Statistics Program, National Corrections Reporting Program. 
Washington, DC: U.S. Department of Justice; 2014. Table 14. Estimated sentenced prisoners under 
state jurisdiction, by offense and sex, race, and Hispanic origin, December 31, 2012. 
58. U.S. Department of Justice. Compendium of Federal Justice Statistics, NCJ 210299. Available 
through Sourcebook of Criminal Justice Statistics Online. Washington, DC: U.S. Department of 
Justice; 2003. Table 6.58.2003. Time served to first release by Federal prisoners by offense, United 
States. 
59. U.S. Department of Justice. Federal Bureau of Prisons, State of the Bureau. Available through 
Sourcebook of Criminal Justice Statistics Online. Washington, DC: U.S. Department of Justice; 
Peterson et al. Page 10













2003. Table 6.0023.2013. Prisoners under the jurisdiction of the Federal Bureau of Prisons by 
adjudication status, type of offense, and sentence length, selected years 1990-2013. 
60. U.S. Department of Justice. Probation and Parole in the United States, NCJ 248029. Washington, 
DC: U.S. Department of Justice; 2014. Table 6. Rate of parole exits, by type of exit, 2008–2013. 
61. U.S. Federal Bureau of Investigation. Crime in the United States 2013. Washington, DC: U.S. 
Department of Justice; 2013. Table 7. Offense analysis: Rape—revised definition. 
62. U.S. Federal Bureau of Investigation. Crime in the United States 2013. Washington, DC: U.S. 
Department of Justice; 2013. Table 25. Percent of offenses cleared by arrest or exceptional means, 
rape—revised definition. 
63. Woolhandler S, Himmelstein DU. Paying for national health insurance—and not getting it. Health 
Aff (Millwood). 2002; 21:88–98. http://dx.doi.org/10.1377/hlthaff.21.4.88. [PubMed: 12117155] 
64. Day, T., McKenna, K., Bowlus, A. The economic costs of violence against women: an evaluation 
of the literature expert brief compiled in preparation for the Secretary-General’s in-depth study on 
all forms of violence against women. New York City NY: United Nations; 2005. 
65. Link CL, Lutfey KE, Steers WD, McKinlay JB. Is abuse causally related to urologic symptoms? 
Results from the Boston Area Community Health (BACH) Survey. Eur Urol. 2007; 52(2):397–
406. http://dx.doi.org/10.1016/j.eururo.2007.03.024. [PubMed: 17383083] 
66. Paras ML, Murad MH, Chen LP. Sexual abuse and lifetime diagnosis of somatic disorders: a 
systematic review and meta-analysis. JAMA. 2009; 302(5):550–561. http://dx.doi.org/10.1001/
jama.2009.1091. [PubMed: 19654389] 
67. U.S. Department of Justice. Age Patterns of Victims of Serious Violent Crime, July 1997, 
NCJ-162031. Washington, DC: U.S. Department of Justice; 1997. 
68. Tjaden, P., Thoennes, N. Full report of the prevalence, incidence, and consequences of violence 
against women: findings from the National Violence Against Women Survey. Washington, DC: 
U.S. Department of Justice; http://dx.doi.org/10.1037/e514172006-001
69. Kilpatrick DG, Acierno R, Resnick HS, Saunders BE, Best CL. A 2-year longitudinal analysis of 
the relationships between violent assault and substance use in women. J Consult Clin Psychol. 
1997; 65(5):834–847. http://dx.doi.org/10.1037/0022-006X.65.5.834. [PubMed: 9337502] 
Peterson et al. Page 11



















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Am J Prev Med. Author manuscript; available in PMC 2017 June 01.
